FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Raben

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Tumor Cell Line

Living Beings

Physiology

Signal Transduction

Co-author Network

Publications

TOP 3
Gangwen Han; Fulun Li; Jianbo Lu; James B Mitchell; David Raben; Yosef Refaeli; Anastasia Sowers; Peter ten Dijke; Donna Wang; Li Bian; Gregory Bird; Ana Cotrim; Yu Deng; J Silvio Gutkind; Qinghong Zhang; Rui Zhao; Xiao-Jing Wang
Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis.
Kristin M Kilbourn; Kate Lusczakoski; Derek Anderson; Evelinn Borrayo; Allison Costenaro; David Raben
Feasibility of EASE: a psychosocial program to improve symptom management in head and neck cancer patients.
Neha Amin; Peter DeWitt; David Raben; Krishna Reddy; David Westerly; Changhu Chen
Sparing the larynx and esophageal inlet expedites feeding tube removal in patients with stage III-IV oropharyngeal squamous cell carcinoma treated with intensity-modulated radiotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Raben (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gangwen Han; Fulun Li; Jianbo Lu; James B Mitchell; David Raben; Yosef Refaeli; Anastasia Sowers; Peter ten Dijke; Donna Wang; Li Bian; Gregory Bird; Ana Cotrim; Yu Deng; J Silvio Gutkind; Qinghong Zhang; Rui Zhao; Xiao-Jing Wang
Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis.
Nature medicine 2013;19(4):421-8.
2013: Kristin M Kilbourn; Kate Lusczakoski; Derek Anderson; Evelinn Borrayo; Allison Costenaro; David Raben
Feasibility of EASE: a psychosocial program to improve symptom management in head and neck cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2013;21(1):191-200.
2012: Neha Amin; Peter DeWitt; David Raben; Krishna Reddy; David Westerly; Changhu Chen
Sparing the larynx and esophageal inlet expedites feeding tube removal in patients with stage III-IV oropharyngeal squamous cell carcinoma treated with intensity-modulated radiotherapy.
The Laryngoscope 2012;122(12):2736-42.
2012: David Raben; Paul A Bunn
Biologically targeted therapies plus chemotherapy plus radiotherapy in stage III non-small-cell lung cancer: a case of the Icarus syndrome?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(32):3909-12.
2012: Thomas J Pugh; Nancy Y Lee; Theresa Pacheco; David Raben
Microcystic adnexal carcinoma of the face treated with radiation therapy: a case report and review of the literature.
Head & neck 2012;34(7):1045-50.
2011: Daniel W Bowles; Changhu Chen; David Raben; Krishna Reddy; Alexander Ree; Todd Wine; Antonio Jimeno
Locoregional recurrence of an HPV-positive squamous cell carcinoma of the head and neck.
Oncology (Williston Park, N.Y.) 2011;25(11):1042-8.
2011: Neha P Amin; D Ross Camidge; Brian D Kavanagh; Moyed Miften; David Raben; Nicole Rochford; Dale Thornton; Laurie E Gaspar
Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(9):1553-62.
2011: Brian D Kavanagh; David Raben
Back to the future: a proton pro/con.
Oncology (Williston Park, N.Y.) 2011;25(7):657, 660, 662-3.
2011: Quentin Diot; Christine Olsen; Brian D Kavanagh; David Raben; Moyed Miften
Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients.
International journal of radiation oncology, biology, physics 2011;79(2):623-32.
2011: Michelle A Stinauer; Brian D Kavanagh; Tracey E Schefter; Rene Gonzalez; Thomas Flaig; Karl Lewis; William Robinson; Mark Chidel; Michael Glode; David Raben
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Radiation oncology (London, England) 2011;6():34.
2010: Kyle E Rusthoven; Steven Feigenberg; David Raben; Madeleine Kane; John I Song; Nicos Nicolaou; Ranee Mehra; Barbara Burtness; John Ridge; Robyn Swing; Miriam Lango; Roger Cohen; Antonio Jimeno; Changhu Chen
Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer.
International journal of radiation oncology, biology, physics 2010;78(4):1020-5.
2010: Thomas J Pugh; Changhu Chen; Rachel Rabinovitch; S Gail Eckhardt; Kyle E Rusthoven; Robyn Swing; David Raben
Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies.
International journal of radiation oncology, biology, physics 2010;78(2):521-6.
2010: Kyle E Rusthoven; David Raben; John I Song; Madeleine Kane; Taghrid A Altoos; Changhu Chen
Survival and patterns of relapse in patients with oral tongue cancer.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2010;68(3):584-9.
2010: Quentin Diot; Christine Olsen; Brian Kavanagh; David Raben; Moyed Miften
Impact of anatomical interventions on the localization of post-prostatectomy cancer patients.
Medical physics 2010;37(2):629-37.
2009: Robert McCammon; Kyle E Rusthoven; Brian D Kavanagh; Sherri Newell; Francis Newman; David Raben
Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
International journal of radiation oncology, biology, physics 2009;75(2):413-20.
2009: Heather M Brechbuhl; Elysia Min; Chirag Kariya; Barbara Frederick; David Raben; Brian Day
Select cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transport.
Free radical biology & medicine 2009;47(6):722-30.
2009: Kyle E Rusthoven; David Raben; Charles Schneider; Robert Witt; Sarah Sammons; Adam Raben
Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.
International journal of radiation oncology, biology, physics 2009;74(5):1365-70.
2009: Thomas W Flaig; Lih-Jen Su; Caroline McCoach; Yuan Li; David Raben; Marileila Varella-Garcia; Lynne T Bemis
Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent manner.
BJU international 2009;103(12):1729-37.
2009: CC Olsen; Tracey E Schefter; Honglin Chen; Madeleine Kane; Stephen Leong; Martin D McCarter; Yang Chen; Philip C Mack; S Gail Eckhardt; Gregory V Stiegmann; David Raben
Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy.
American journal of clinical oncology 2009;32(2):115-21.
2008: Kyle E Rusthoven; David Raben; Changhu Chen
Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality.
International journal of radiation oncology, biology, physics 2008;72(2):343-50.
2008: Erica L Bradshaw-Pierce; Courtney A Steinhauer; David Raben; Daniel L Gustafson
Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human squamous cell carcinoma.
Molecular cancer therapeutics 2008;7(9):3006-17.
2008: Ari Ballonoff; Brian D Kavanagh; Martin McCarter; Madeleine Kane; Nathan W Pearlman; Russell Nash; Raj J Shah; David Raben; Tracey E Schefter
Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
American journal of clinical oncology 2008;31(3):264-70.
2008: Ari Ballonoff; David Raben; Kyle E Rusthoven; Michael Bassetti; Madeleine Kane; John I Song; Changhu Chen
Outcomes of patients with n3 neck nodes treated with chemoradiation.
The Laryngoscope 2008;118(6):995-8.
2008: Kyle Rusthoven; Changhu Chen; David Raben; Brian D Kavanagh
Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
International journal of radiation oncology, biology, physics 2008;71(1):192-8.
2008: Kyle E Rusthoven; David Raben; Ari Ballonoff; Madeleine Kane; John I Song; Changhu Chen
Effect of radiation techniques in treatment of oropharynx cancer.
The Laryngoscope 2008;118(4):635-9.
2008: Kyle E Rusthoven; Thomas W Flaig; David Raben; Brian D Kavanagh
High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Clinical lung cancer 2008;9(2):106-11.
2008: Daniel L Gustafson; Barbara Frederick; Andrea L Merz; David Raben
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts.
Cancer chemotherapy and pharmacology 2008;61(2):179-88.
2008: Kyle Rusthoven; Ari Ballonoff; David Raben; Changhu Chen
Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.
Cancer 2008;112(2):345-51.
2007: Changhu Chen; Madeleine Kane; John Song; John P Campana; Adam Raben; Kenneth Hu; Louis B Harrison; Harry Quon; Janet Dancey; Anna Baron; Sherif Said; S Gail Eckhardt; David Raben
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4880-6.
2007: Barbara A Frederick; Barbara Helfrich; Christopher Coldren; Di Zheng; Dan Chan; Paul A Bunn; David Raben
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma.
Molecular cancer therapeutics 2007;6(6):1683-91.
2006: Barbara Helfrich; David Raben; Marileila Varella-Garcia; Dan Gustafson; Daniel C Chan; Lynne Bemis; Chris Coldren; Anna E Barón; Chan Zeng; Wilbur A Franklin; Fred R Hirsch; Adi F Gazdar; John D Minna; Paul A Bunn
Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7117-25.
2006: Cataldo Bianco; Elisa Giovannetti; Fortunato Ciardiello; Valentina Mey; Sara Nannizzi; Giampaolo Tortora; Teresa Troiani; Francesco Pasqualetti; Gail Eckhardt; Mario de Liguoro; Simona Ricciardi; Mario Del Tacca; David Raben; Luca Cionini; Romano Danesi
Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7099-107.
2006: Brian L Rothschild; Ann H Shim; Amanda Gatesman Ammer; Laura C Kelley; Kimberly B Irby; Julie A Head; Lin Chen; Marileila Varella-Garcia; Peter G Sacks; Barbara Frederick; David Raben; Scott A Weed
Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Cancer research 2006;66(16):8017-25.
2006: Brian D Kavanagh; David Raben
Toward a unified target theory in oncology.
Future oncology (London, England) 2006;2(4):435-6.
2006: Karl D Lewis; Susan Dollarhide; James E Fitzpatrick; Rene Gonzalez; Whitney A High; Martin D McCarter; Christine Olsen; David Raben
Metastatic malignant melanoma from an unknown primary presenting as a large axillary mass.
Oncology (Williston Park, N.Y.) 2006;20(7):763-70.
2006: Ari Ballonoff; Changhu Chen; David Raben
Current radiation therapy management issues in oral cavity cancer.
Otolaryngologic clinics of North America 2006;39(2):365-80.
2006: Rachel Rabinovitch; Barbara Grant; Brian A Berkey; David Raben; K. Kian Ang; Karen K Fu; Jay S Cooper
Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
Head & neck 2006;28(4):287-96.
2006: Brian D Kavanagh; Tracey E Schefter; Higinia R. Cardenes; Volker W Stieber; David Raben; Robert D Timmerman; Martin D McCarter; Stuart Burri; Lucien A Nedzi; Timothy E Sawyer; Laurie E Gaspar
Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.
Acta oncologica (Stockholm, Sweden) 2006;45(7):848-55.
2006: Barbara Frederick; Dan Gustafson; Cataldo Bianco; Fortunato Ciardiello; Isaiah Dimery; David Raben
ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy.
International journal of radiation oncology, biology, physics 2006;64(1):33-7.
2005: David Raben; Anderson Ryan
Vascular-targeting agents and radiation therapy in lung cancer: where do we stand in 2005?
Clinical lung cancer 2005;7(3):175-9.
2005: Vincenzo Damiano; Davide Melisi; Cataldo Bianco; David Raben; Rosa Caputo; Gabriella Fontanini; Roberto Bianco; Anderson Ryan; Angelo Raffaele Bianco; Sabino De Placido; Fortunato Ciardiello; Giampaolo Tortora
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5639-44.
2005: Meisong Ding; Francis Newman; David Raben
New radiation therapy techniques for the treatment of head and neck cancer.
Otolaryngologic clinics of North America 2005;38(2):371-95, vii-viii.
2005: David Raben; Barbara Helfrich; Daniel C Chan; Fortunato Ciardiello; LiMin Zhao; Wilbur Franklin; Anna E Barón; Chan Zeng; Tim K Johnson; Paul A Bunn
The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):795-805.
2004: David Raben; Cataldo Bianco; Vincenzo Damiano; Roberto Bianco; Davide Melisi; Chiara Mignogna; Francesco P D'Armiento; Luca Cionini; Angelo Raffaele Bianco; Giampaolo Tortora; Fortunato Ciardiello; Paul A Bunn
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
Molecular cancer therapeutics 2004;3(8):977-83.
2004: David Raben; Barbara Helfrich
Angiogenesis inhibitors: a rational strategy for radiosensitization in the treatment of non-small-cell lung cancer?
Clinical lung cancer 2004;6(1):48-57.
2004: David Raben; Cataldo Bianco; Luka Milas; K. Kian Ang
Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
Seminars in radiation oncology 2004;14(2):139-52.
2004: David Raben; Barbara Helfrich; Paul A Bunn
Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
International journal of radiation oncology, biology, physics 2004;59(2 Suppl):27-38.
2003: Paul Okunieff; Raymond E Meyn; Beverly A Teicher; Charles Thomas; Laurie E Gaspar; David Raben; Shankar Giri; Robert S Lavey; Andrew T Turrisi; Gregory Swanson; Stephen R Smalley
Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003.
American journal of clinical oncology 2003;26(5):522-9.
2003: David Raben; Barbara Helfrich; Fortunato Ciardiello; Paul A Bunn
Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S15-22.
2003: Giuseppe Di Lorenzo; Riccardo Autorino; Fortunato Ciardiello; David Raben; Cataldo Bianco; Teresa Troiani; Carmine Pizza; Michele De Laurentiis; Matilde Pensabene; Massimo D'Armiento; Angelo Raffaele Bianco; Sabino De Placido
External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life.
Oncology reports 2003;10(2):399-404.
2002: Cataldo Bianco; Giampaolo Tortora; Roberto Bianco; Roberta Caputo; Bianca Maria Veneziani; Rosa Caputo; Vincenzo Damiano; Teresa Troiani; Gabriella Fontanini; David Raben; Stefano Pepe; Angelo Raffaele Bianco; Fortunato Ciardiello
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3250-8.
2002: David Raben; Cataldo Bianco; Barbara Helfrich; Elaine Weng; Fortunato Ciardiello; Paul M Harari
Interference with EGFR signaling: paradigm for improving radiation response in cancer treatment.
Expert review of anticancer therapy 2002;2(4):461-71.
2002: David Raben; Barbara Helfrich; Dan Chan; Gary Johnson; Paul A Bunn
ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer.
Seminars in oncology 2002;29(1 Suppl 4):37-46.
2000: Hoyt A Childs; T Cole; Elizabeth Falkenberg; J T Smith; Jorge E Alonso; James P Stannard; Sharon A Spencer; John B Fiveash; David Raben; James A. Bonner; Andrew Westfall; Robert Y Kim
A prospective evaluation of the timing of postoperative radiotherapy for preventing heterotopic ossification following traumatic acetabular fractures.
International journal of radiation oncology, biology, physics 2000;47(5):1347-52.
2000: Hoyt A Childs; Sharon A Spencer; David Raben; James A. Bonner; J Newsome; Francisco Robert
A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer.
International journal of radiation oncology, biology, physics 2000;47(4):939-44.
2000: S A Tincher; Robert Y Kim; MP Ezekiel; T Zinsli; John B Fiveash; David Raben; Anton J Bueschen; Donald A Urban
Effects of pelvic rotation and needle angle on pubic arch interference during transperineal prostate implants.
International journal of radiation oncology, biology, physics 2000;47(2):361-3.
1999: Francisco Robert; David Raben; S Spencer
UFT/oral calcium folinate plus radiation in pancreatic cancer.
Oncology (Williston Park, N.Y.) 1999;13(7 Suppl 3):127-8.
1998: Ryan Miller; Donald J Buchsbaum; Paul N Reynolds; Joanne T Douglas; G Yancey Gillespie; MS Mayo; David Raben; David T Curiel
Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.
Cancer research 1998;58(24):5738-48.
1996: Donald J Buchsbaum; David Raben; Murray A Stackhouse; Muhammad B Khazaeli; Buck E Rogers; M E Rosenfeld; T Liu; David T Curiel
Approaches to enhance cancer radiotherapy employing gene transfer methods.
Gene therapy 1996;3(12):1042-68.
1996: David Raben; Donald J Buchsbaum; Muhammad B Khazaeli; M E Rosenfeld; G Yancey Gillespie; W E Grizzle; T Liu; David T Curiel
Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene.
Gene therapy 1996;3(7):567-80.